Publications by authors named "Sandra Biroc"

Claim this Profile
A
ARX788, a Site-specific Anti-HER2 Antibody-Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1-resistant Breast and Gastric Cancers.
Lillian Skidmore, Sukumar Sakamuri, Nick A Knudsen, Amha Gebre Hewet, Snezana Milutinovic, Sandra Lyn Biroc

Mol Cancer Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Efficacy Study Showing Comparative Advantage of Bacterial Infection Prevention with Zip-type Skin Closure Device vs. Subcuticular Sutures.
Bauback Safa, Amir Belson, Carol Meschter, Michelle Kelley, Daren Stewart, Sandra Biroc

Cureus· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A general approach to site-specific antibody drug conjugates.
Feng Tian, Yingchun Lu, Anthony Manibusan, Aaron Sellers, Hon Tran, Sandra L Biroc

Proc Natl Acad Sci U S A· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruiting cytotoxic T cells to folate-receptor-positive cancer cells.
Sumith A Kularatne, Vishal Deshmukh, Marco Gymnopoulos, Sandra L Biroc, Jinming Xia

Angew Chem Int Ed Engl· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific small molecule-antibody conjugate targeting prostate cancer.
Chan Hyuk Kim, Jun Y Axup, Brian R Lawson, Hwayoung Yun, Virginie Tardif, Sandra L Biroc

Proc Natl Acad Sci U S A· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids.
Jun Y Axup, Krishna M Bajjuri, Melissa Ritland, Benjamin M Hutchins, Chan Hyuk Kim, Sandra L Biroc

Proc Natl Acad Sci U S A· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent triazolothione inhibitor of heat-shock protein-90.
Richard I Feldman, Bob Mintzer, Daguang Zhu, James M Wu, Sandra L Biroc

Chem Biol Drug Des· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
Han Ying, Sandra L Biroc, Wei-Wei Li, Bruno Alicke, Jian-Ai Xuan

Mol Cancer Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis.
Shauntae M McDaniel, Kristen K Rumer, Sandra L Biroc, Richard P Metz, Meenakshi Singh

Am J Pathol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth.
David Kiewlich, Jianhuan Zhang, Cynthia Gross, Wei Xia, Brent Larsen, Sandra Biroc

Neoplasia· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.
Renate Parry, Doug Schneider, Debra Hudson, Debbie Parkes, Jian-Ai Xuan, Sandra Biroc

Cancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models.
Deborah A Zajchowski, Sandra L Biroc, Hsaio-Lai Liu, Steven K Chesney, Jens Hoffmann

Int J Cancer· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1.
Richard I Feldman, James M Wu, Mark A Polokoff, Monica J Kochanny, Harald Dinter, Sandra L Biroc

J Biol Chem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tomoregulin for radioimmunotherapy of prostate cancer.
Xiao-Yan Zhao, Doug Schneider, Sandra L Biroc, Renate Parry, Bruno Alicke

Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors.
T Charis Wagner, Sharlene Velichko, Steven K Chesney, Sandra Biroc, Dean Harde

Int J Cancer· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis